Author:
Qi Jun-Juan,Liu Ling,Cao Ji-Xiang,An Guo-Shun,Li Shu-Yan,Li Gang,Jia Hong-Ti,Ni Ju-Hua
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine
Reference38 articles.
1. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei Y, Nakamura Y (2000) A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404:42–49. doi: 10.1038/35003506
2. Guittet O, Hakansson P, Voevodskaya N, Fridd S, Graslund A, Arakawa H, Nakamura Y, Thelander L (2001) Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells. J Biol Chem 276:40647–40651. doi: 10.1074/jbc.M106088200
3. Xue L, Zhou B, Liu X, Qiu W, Jin Z, Yen Y (2003) Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits. Cancer Res 63:980–986
4. Wang X, Zhenchuk A, Wiman KG, Albertioni F (2009) Regulation of p53R2 and its role as potential target for cancer therapy. Cancer Lett 276:1–7. doi: 10.1016/j.canlet.2008.07.019
5. Hakansson P, Hofer A, Thelander L (2006) Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damageand in resting cells. J Biol Chem 281:7834–7841. doi: 10.1074/jbc.M512894200
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献